Overall rank by patents
#31,737
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 22 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c).
The verdict
According to USPTO PatentsView, Garmor ranks #31,737 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 22 technology areas.
USPTO PatentsView assignee plate
Corpus R31737 · US Corporation #31,737 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Galvanize Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Garmor · this assignee
36 score
3D Lighting… · lowest
7 score
What this shows Garmor's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Garmor Inc. is a focused PatentsView assignee: 22 CPC subclasses with 62.5% of grants classified under C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2017. By volume, Garmor sits between Galvanize Therapeutics, Inc. and Geisinger Clinic.
Garmor Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Galvanize Therapeutics, Inc.
8 patents
GangaGen, Inc.
8 patents
Gaplast GmbH
8 patents
Gardyn Inc.
8 patents
Gartner, Inc.
8 patents
GattaCo Inc.
8 patents
Gebr. Kemper GmbH + Co. KG Metallwerke
8 patents
Geisinger Clinic
8 patents
Garmor Inc.
8 patents
What this shows Garmor holds 8 patents at rank #31,800, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,800 in granted patent volume.
Other assignees with the most granted patents in Garmor's primary technology class.
Garmor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 2 | 25.0% |
| 2021 | 2 | 25.0% |
| 2022 | 1 | 12.5% |
Top 15 of 22 technology areas
Overall rank by patents
#31,737
of 49,997 tracked assignees
35.6 out of 100
What to do with this data
Garmor Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.